0

COPD and Asthma Diagnostic and Monitoring Devices Market: Current Analysis and Forecast (2021-2027)

Region:Global

Author(s):

Product Code:UMHE21249

Download Sample Report download
Buy the Full ReportStarting from $3500
Published on

June 2021

Total pages

208

Table of Content

Download Sample Report download
Buy the Full ReportStarting from $3500

About the Report

About the Report

ASTHMA AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) DEVICES ARE MAINLY USED AS RESCUE THERAPY FOR DISEASES RELATED TO RESPIRATION. ASTHMA AND COPD BOTH SHOW SIMILAR KINDS OF SYMPTOMS SUCH AS WHEEZING, COUGHING, AND SHORTNESS OF BREATH. BUT, COPD GENERALLY OUTLINES PROGRESSIVE RESPIRATORY DISEASES SUCH AS CHRONIC BRONCHITIS AND EMPHYSEMA. MOREOVER, THERE ARE DECREASED LEVELS OF RESPIRATORY AIRFLOW AND THE INFLAMMATION OF AIRWAY TISSUES IN THE CASE OF COPD. ACCORDING TO THE NATIONAL INSTITUTES OF HEALTH (NIH), MORE THAN 16 MILLION AMERICANS ARE SUFFERING FROM THE CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD).

THE DEMAND FOR COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES IS INCREASING ON ACCOUNT OF THE RISING INCIDENCE OF ASTHMA AND COPD CASES, RISE IN THE AGING POPULATION, GROWING POPULATION OF TOBACCO SMOKERS, INCREASE IN URBANIZATION AND POLLUTION, RISING CASE OF PRETERM BIRTH, AND LIFESTYLE CHANGES. FURTHERMORE, INCREASING GOVERNMENT INITIATIVES AND THE FOCUS OF PHARMACEUTICAL COMPANIES TO MANUFACTURE AN ADVANCED AND PORTABLE INHALATION DEVICE, FURTHER DRIVES THE MARKET GROWTH. FOR INSTANCE, LUPIN LAUNCHED ADHERO, A CONNECTED SMART DRUG DELIVERY DEVICE IN INDIA FOR THE TREATMENT OF RESPIRATORY DISEASES SUCH AS COPD AND ASTHMA. AHEREO CAN BE ATTACHED TO A METERED-DOSE INHALER (MDI), HAVING BLUETOOTH-LIKE FEATURES WHICH CAN BE USED TO TRACK THE DAILY MEDICATION RECORD OF PATIENTS THROUGH MYADHERO ON SMARTPHONES. HOWEVER, SOME OF THE RESTRAINTS IN THE MARKET INCLUDE THE HIGH COST OF DEVICES, AND DEGRADATION OF MATERIAL QUALITY AFTER SOME TIME.

BASED ON THERAPEUTIC DEVICES, THE MARKET IS FRAGMENTED INTO VENTILATOR, MASK, PAP (POSITIVE AIRWAY PRESSURE) DEVICE, INHALER, AND NEBULIZER. INHALERS SUB-SEGMENT IS EXPECTED TO DOMINATE THE MARKET OWING TO ITS LOW COORDINATION WITH THE PATIENT AND EASY TO USE FEATURE. INHALERS ARE GENERALLY OF TWO TYPES METERED-DOSE INHALERS (MDIS) AND DRY-POWDER INHALERS (DPIS). MDI PROVIDES SLOW DEEP INHALATION AND IS PROPELLANT BASED WHILE DPI PROVIDES RAPID DEEP INHALATION AND IS NON-PROPELLANT-BASED. GERMAN REMEDIES LAUNCHED NOVOLIZER IS A (DPI) APPROVED FOR USE WITH SALBUTAMOL (ALBUTEROL) AND BUDESONIDE, FOR THE TREATMENT OF ASTHMA AND COPD ATTACKS.

BASED ON MONITORING DEVICES, THE MARKET IS SEGMENTED INTO PULSE OXIMETERS, CAPNOGRAPHY, AND GAS ANALYZERS. THE PULSE OXIMETERS SEGMENT IS EXPECTED TO DOMINATE THE MARKET OWING TO ITS FAST AND ACCURATE RESULTS. FURTHERMORE, THE RISING AWARENESS REGARDING THE APPLICATIONS OF A PULSE OXIMETER IN COVID-19 MANAGEMENT AND THE HIGH PREVALENCE OF RESPIRATORY DISEASES ALSO PROPELS THE MARKET GROWTH. BASED ON DIAGNOSTIC DEVICES, THE MARKET IS FRAGMENTED INTO SPIROMETERS, POLYSOMNOGRAPHY (PSG) DEVICES, PEAK FLOW METERS, AND OTHER DIAGNOSTIC DEVICES. PEAK FLOW METER DEVICES ARE EXPECTED TO DOMINATE THE MARKET IN THE UPCOMING PERIOD OWING TO THEIR LIGHTWEIGHT, EASY TO HANDLE, AND STORE. FURTHERMORE, THESE DEVICES CAN BE CONNECTED REMOTELY FOR THE DIAGNOSIS OF RESPIRATION RATE. FOR INSTANCE, THE MICROLIFE PF 100 IS A DIGITAL MEASURING DEVICE FOR THE DETECTION OF PEAK EXPIRATORY FLOW (PEF) AS WELL AS FORCED EXPIRATORY VOLUME FOR THE MONITORING OF RESPIRATION RATE IN ASTHMATIC PATIENTS.

BASED ON INDICATION, THE MARKET IS SEGMENTED INTO ASTHMA AND COPD. THE ASTHMA SUB-SEGMENT IS EXPECTED TO DOMINATE THE MARKET OWING TO THE RISE IN OUTDOOR AND INDOOR CAUSATIVE AGENTS SUCH AS ALLERGENS, DUST, AND POLLUTION. AS PER WORLD HEALTH ORGANIZATION (2019), ASTHMA AFFECTED AN ESTIMATED 262 MILLION PEOPLE IN 2019 AND CAUSED 461000 DEATHS, WORLDWIDE. BASED ON END-USER, THE MARKET IS FRAGMENTED INTO HOMECARE, HOSPITALS, CLINICS, AND OTHER END-USERS. HOSPITAL SUB-SEGMENT IS EXPECTED TO DOMINATE THE MARKET OWING TO AN INCREASE IN THE NUMBER OF PATIENTS SUFFERING FROM RESPIRATORY DISEASES, A RISE IN GOVERNMENT INITIATIVES, AND ADVANCEMENTS IN TECHNOLOGY IN TERMS OF COPD AND ASTHMA DEVICES.

FOR A BETTER UNDERSTANDING OF THE MARKET ADOPTION OF THE COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES, THE MARKET IS ANALYZED FOR MAJOR REGIONS INCLUDING NORTH AMERICA (UNITED STATES, CANADA, AND THE REST OF NORTH AMERICA), EUROPE (GERMANY, FRANCE, ITALY, SPAIN, UNITED KINGDOM AND REST OF EUROPE), ASIA-PACIFIC (CHINA, JAPAN, INDIA, AUSTRALIA, AND REST OF APAC), AND REST OF WORLD. NORTH AMERICA DOMINATED THE MARKET IN 2020, ON ACCOUNT OF THE HIGHLY DEVELOPED HEALTHCARE INFRASTRUCTURE, HUGE HEALTHCARE SPENDING, AND PRESENCE OF A LARGE NUMBER OF MARKET PLAYERS IN THE US. AS PER THE ASTHMA AND ALLERGY FOUNDATION OF AMERICA, AROUND 25 MILLION AMERICANS HAVE ASTHMA. THIS EQUALS TO ABOUT 1 IN 13 AMERICANS, INCLUDING 8% OF ADULTS AND 7% OF CHILDREN.

SOME OF THE MAJOR PLAYERS OPERATING IN THE MARKET INCLUDE DRAGERWERK AG & CO. KGAA, GETINGE AB, INVACARE CORPORATION, MASIMO CORPORATION, VYAIRE MEDICAL INC., KONINKLIJKE PHILIPS N.V, BECTON DICKINSON AND COMPANY, NIHON KOHDEN CORPORATION, SMITHS MEDICAL, AND MEDTRONIC PLC. SEVERAL M&AS ALONG WITH PARTNERSHIPS HAVE BEEN UNDERTAKEN BY THESE PLAYERS TO BOOST THEIR PRESENCE IN DIFFERENT REGIONS.

Products


Companies

DRAGERWERK AG & CO. KGAA

GETINGE AB

INVACARE CORPORATION

MASIMO CORPORATION

VYAIRE MEDICAL INC.

KONINKLIJKE PHILIPS N.V

BECTON DICKINSON AND COMPANY

NIHON KOHDEN CORPORATION

SMITHS MEDICAL

AND MEDTRONIC PLC.

Table of Contents

Table of Contents

1 MARKET INTRODUCTION

1.1 MARKET DEFINITIONS

1.2 LIMITATIONS

1.3 STAKE HOLDERS

1.4 CURRENCY USED IN REPORT

2 RESEARCH PROCESS & RESEARCH METHODOLOGY

2.1 RESEARCH PROCESS OF THE COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET

2.2 RESEARCH METHODOLOGY OF THE COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET

2.3 FORECASTING METHOD

2.4 RESPONDENT PROFILE

2.5 MAIN OBJECTIVE OF THE COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET STUDY

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 GLOBAL COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET ANALYSIS 2019-27F

6 MARKET INSIGHTS BY THERAPEUTIC DEVICES

6.1 VENTILATOR

6.2 MASK

6.3 PAP (POSITIVE AIRWAY PRESSURE) DEVICE

6.4 INHALER

6.5 NEBULIZER

7 MARKET INSIGHTS BY MONITORING DEVICES

7.1 PULSE OXIMETERS

7.2 CAPNOGRAPHS

7.3 GAS ANALYSERS

8 MARKET INSIGHTS BY DIAGNOSTIC DEVICES

8.1 SPIROMETERS

8.2 POLYSOMNOGRAPHY (PSG) DEVICES

8.3 PEAK FLOW METERS

8.4 OTHER DIAGNOSTIC DEVICES

9 MARKET INSIGHTS BY INDICATION

9.1 ASTHMA

9.2 COPD

10 MARKET INSIGHTS BY END-USER

10.1 HOMECARE

10.2 HOSPITALS

10.3 CLINICS

10.4 OTHER END-USERS

11 MARKET INSIGHTS BY REGION

11.1 NORTH AMERICA COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET

11.1.1 UNITED STATES

11.1.2 CANADA

11.1.3 REST OF NORTH AMERICA

11.2 EUROPE COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET

11.2.1 GERMANY

11.2.2 FRANCE

11.2.3 UNITED KINGDOM

11.2.4 ITALY

11.2.5 SPAIN

11.2.6 REST OF EUROPE

11.3 ASIA PACIFIC COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET

11.3.1 CHINA

11.3.2 JAPAN

11.3.3 INDIA

11.3.4 AUSTRALIA

11.3.5 REST OF ASIA PACIFIC

11.4 REST OF WORLD COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET

12 DEMAND AND SUPPLY SIDE ANALYSIS

12.1 DEMAND SIDE ANALYSIS

12.2 SUPPLY SIDE ANALYSIS

12.1.1 TOP PRODUCT LAUNCHES

12.1.2 TOP BUSINESS PARTNERSHIPS

12.1.3 TOP BUSINESS EXAPNSIONS, INVESTMENTS AND DIVERSTITURES

12.1.4 TOP MERGER AND ACQUISITIONS

13 VALUE CHAIN ANALYSIS

14 GLOBAL COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET TRENDS & INSIGHTS

15 GLOBAL COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET DYNAMICS

15.1 DRIVERS

15.2 CHALLENGES

15.3 IMPACT ANALYSIS

16 GLOBAL COPD AND ASTHMA DIAGNOSTIC AND MONITORING DEVICES MARKET OPPORTUNITIES

17 COMPETITIVE SCENARIO

18 COMPANY PROFILED

18.1 DRAGERWERK AG & CO KGAA

18.2 GETINGE AB

18.3 INVACARE CORPORATION

18.4 MASIMO CORPORATION

18.5 VYAIRE MEDICAL INC

18.6 KONINKLIJKE PHILIPS NV

18.7 BECTON DICKINSON AND COMPANY

18.8 NIHON KOHDEN CORPORATION

18.9 SMITHS MEDICAL

18.10 MEDTRONIC PLC

19 DISCLAIMER

You can also purchase parts of this report.
Do you want to check out a section wise price list?
Get Price Break-up

Why Buy From US?

RRR
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story

reach
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Research
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

Insite
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Client Choose Us?

400000+ Reports in repository
150+ Consulting project a year
100+ Analysts
8000+ Client Queries in 2022